Skip to main content

Table 1 Participant characteristics at baseline and follow-up according to CD condition

From: Serum albumin to globulin ratio is related to cognitive decline via reflection of homeostasis: a nested case-control study

 

All

 

Male

 

Female

Number

Data are mean ± SD, median [range] or (%)

p value

Number

Data are mean ± SD, median [range] or (%)

p value

Number

Data are mean ± SD, median [range] or (%)

p value

Control

CD

Control

CD

Control

CD

Control

CD

Control

CD

Control

CD

Baseline

 Age (years)

117

34

59.4 ± 5.9

61.2 ± 4.6

0.066

82

19

59.9 ± 6.2

61.2 ± 4.6

0.128

35

15

58.2 ± 5.3

59.9 ± 4.3

0.280

 Sex (Female)

35

15

29.9 (%)

44.1 (%)

0.148

          

 BMI (kg/m2)

117

34

22.3 ± 2.4

22.6 ± 3.3

0.590

82

19

22.5 ± 2.3

23.0 ± 2.1

0.379

35

15

21.8 ± 2.8

22.0 ± 4.4

0.844

 SBP (mmHg)

117

34

124 ± 18.6

124 ± 19.0

0.974

82

19

124 ± 15.7

130 ± 20.8

0.118

35

15

124 ± 24.4

116 ± 12.9

0.122

 DBP (mmHg)

117

34

72.8 ± 9.5

73.0 ± 10.9

0.916

82

19

73.8 ± 8.9

74.6. ± 12.5

0.804

35

15

70.4 ± 10.6

71.0 ± 8.43

0.852

 Triglyceride (mg/dl)

115

34

98.7 ± 52.3

103 ± 47.4

0.604

81

19

102 ± 56.2

120 ± 51.8

0.198

34

15

90.1 ± 40.8

82.7 ± 31.5

0.537

 Total cholesterol (mg/dl)

115

34

211 ± 30.1

224 ± 43.2

0.108

81

19

208 ± 28.8

209 ± 37.4

0.938

34

15

219 ± 32.2

244 ± 42.9

0.029

 HDL-C (mg/dl)

115

34

68.0 ± 18.4

63.5 ± 16.0

0.205

81

19

64.1 ± 18.4

55.7 ± 11.5

0.061

34

15

77.1 ± 15.2

73.4 ± 15.6

0.437

 non-HDL-C (mg/dl)

115

34

141 ± 37.7

161 ± 42.4

0.009

82

19

142 ± 36.5

153 ± 40.5

0.259

35

15

138 ± 40.8

171 ± 43.9

0.014

 Total Protein (g/dl)

115

34

7.14 ± 0.39

7.33 ± 0.33

0.012

81

19

7.11 ± 0.39

7.22 ± 0.31

0.276

34

15

7.22 ± 0.37

7.47 ± 0.32

0.027

 Albumin (g/dl)

115

34

4.40 ± 0.21

4.41 ± 0.19

0.751

81

19

4.42 ± 0.22

4.39 ± 0.23

0.626

34

15

4.36 ± 0.18

4.45 ± 0.15

0.137

 A/G ratio

99

30

1.87 ± 0.21

1.74 ± 0.16

0.002

71

18

1.91 ± 0.22

1.78 ± 0.16

0.025

28

12

1.78 ± 0.17

1.68 ± 0.16

0.084

 Creatinine (mg/dl)

115

34

0.94 ± 0.14

0.94 ± 0.23

0.850

81

19

1.00 ± 0.12

1.04 ± 0.25

0.277

34

15

0.81 ± 0.10

0.80 ± 0.11

0.816

 Uric acid (mg/dl)

115

34

5.47 ± 1.18

5.30 ± 1.37

0.466

81

19

5.89 ± 1.03

5.75 ± 1.54

0.620

34

15

4.47 ± 0.91

4.73 ± 0.87

0.369

 HbA1c

117

34

5.05 ± 0.77

5.34 ± 0.66

0.044

82

19

5.09 ± 0.71

5.43 ± 0.81

0.076

35

15

4.98 ± 0.88

5.24 ± 0.41

0.228

 hsCRP (mg/dl)

71

26

0.09 ± 0.07

0.11 ± 0.11

0.347

54

15

0.08 ± 0.07

0.13 ± 0.13

0.183

17

11

0.10 ± 0.08

0.08 ± 0.09

0.559

C. pneumoniae seropositivity

39

14

33.3 (%)

41.2 (%)

0.420

25

11

30.5 (%)

57.9 (%)

0.034

14

3

40.0 (%)

20.0 (%)

0.209

H. pylori seropositivity

58

27

49.6 (%)

79.4 (%)

0.003

37

15

45.1 (%)

78.9 (%)

0.010

21

12

60.0 (%)

80.0 (%)

0.209

ApoE4 carrier

25

6

21.4 (%)

17.7 (%)

0.633

15

4

18.2 (%)

21.1 (%)

0.756

10

2

28.6 (%)

13.3 (%)

0.466

ApoE4 not determined

2

1

1.71 (%)

2.94 (%)

 

2

0

2.43 (%)

0 (%)

 

0

1

0 (%)

6.67 (%)

 

Anamnesis

 Hypertension

35

14

29.9 (%)

41.2 (%)

0.298

22

11

26.8 (%)

57.9 (%)

0.015

13

3

37.1 (%)

20.0 (%)

0.328

 Hyperlipidemia

18

6

15.3 (%)

17.6 (%)

0.793

15

5

18.3 (%)

26.3 (%)

0.525

3

1

8.57 (%)

6.67 (%)

1.000

 Diabetes

21

8

18.0 (%)

23.5 (%)

0.471

17

5

20.7 (%)

26.3 (%)

0.759

4

3

11.4 (%)

20.0 (%)

0.415

 History of stroke

1

0

0.86 (%)

0 (%)

1.000

0

0

0 (%)

0 (%)

 

1

0

2.86 (%)

0 (%)

1.000

Education

  < 13 year

53

23

45.3 (%)

67.6 (%)

0.049

32

12

39.0 (%)

63.2 (%)

0.122

21

11

60.0 (%)

73.3 (%)

0.526

  ≥ 13 year

60

11

51.3 (%)

32.4 (%)

47

7

57.3 (%)

36.8 (%)

13

4

37.1 (%)

26.7 (%)

 Not determined

4

0

3.42 (%)

0 (%)

 

3

0

3.66 (%)

0 (%)

 

1

0

2.86 (%)

0 (%)

 

Alcohol drinking

 Current

78

15

66.7 (%)

44.1 (%)

0.067

67

13

81.7 (%)

68.4 (%)

0.301

11

2

31.4 (%)

13.3 (%)

0.297

 Former

3

2

2.56 (%)

5.88 (%)

3

2

3.66 (%)

10.5 (%)

0

0

0 (%)

0 (%)

 Never

35

16

29.9 (%)

47.0 (%)

11

4

13.4 (%)

21.1 (%)

24

12

68.6 (%)

80.0 (%)

 Not determined

1

1

0.86 (%)

2.94 (%)

 

1

0

1.22 (%)

0 (%)

 

0

1

0 (%)

6.67 (%)

 

Smoking (%)

 Current

21

7

17.9 (%)

20.6 (%)

0.758

20

7

24.4 (%)

36.8 (%)

0.561

1

0

2.86 (%)

0 (%)

0.221

 Former

40

9

34.2 (%)

26.5 (%)

40

8

48.8 (%)

42.1 (%)

0

1

0 (%)

6.67 (%)

 Never

54

16

46.2 (%)

47.1 (%)

21

4

25.6 (%)

21.1 (%)

33

12

94.3 (%)

80.0 (%)

 Not determined

2

2

1.71 (%)

5.88 (%)

 

1

0

1.22 (%)

0 (%)

 

1

2

2.86 (%)

13.3 (%)

 

In 2006-2008

 MMSE

117

34

29.5 ± 0.71

29.0 ± 0.75

<0.001

82

19

29.6 ± 0.64

29.3 ± 0.67

0.092

35

15

29.4 ± 0.85

28.6 ± 0.72

0.004

  Ta

117

34

10 [4-18]

9 [4-18]

0.274

82

19

10 [4-18]

9 [4-18]

0.501

35

15

10 [4-18]

8 [4-18]

0.469

  Ka

117

34

12 [2-21]

11 [5-17]

0.052

82

19

12 [4-21]

11 [5-17]

0.100

35

15

12 [2-21]

10 [6-17]

0.425

 Pulse wave velocity (m/sec)

116

34

15.2 ± 2.68

16.6 ± 2.73

0.013

81

19

15.4 ± 2.56

17.8 ± 2.94

<0.001

35

15

14.9 ± 2.95

14.9 ± 1.25

0.959

In 2012-2014

 MMSE

117

34

29.5 ± 0.67

26.0 ± 0.88

<0.001

82

19

29.6 ± 0.54

25.8 ± 0.87

<0.001

35

15

29.3 ± 0.87

26.1 ± 0.91

<0.001

 Verbal fluency tasks

  Ta

117

34

9 [2-17]

8 [3-24]

0.026

82

19

9 [2-15]

8 [4-13]

0.055

35

15

9 [2-17]

8 [3-24]

0.237

  Ka

117

34

10 [3-20]

9 [5-18]

0.038

82

19

10 [3-20]

9 [5-18]

0.440

35

15

10 [3-20]

8 [5-14]

0.017

 Pulse wave velocity (m/sec)

116

34

17.0 ± 2.99

18.5 ± 3.28

0.011

81

19

17.2 ± 2.65

19.4 ± 3.76

0.026

35

15

16.4 ± 3.64

17.4 ± 2.20

0.329

 IADL

117

34

13 [9-13]

13 [7-13]

0.463

81

19

13 [9-13]

13 [9-13]

0.595

35

15

13 [10-13]

13 [7-13]

0.580

 METs

117

34

14.5 [2.0-48.4]

16.9 [1.5-50.4]

0.161

81

19

15.2 [2.5-48.4]

17.1 [1.5-50.4]

0.195

35

15

14.5 [2.0-42.5]

14.2 [1.5-40.0]

0.335

Anamnesis

 Hypertension

63

20

53.9 (%)

58.8 (%)

0.697

45

15

54.9 (%)

78.9 (%)

0.071

18

5

51.4 (%)

33.3 (%)

0.355

 Hyperlipidemia

61

25

52.1 (%)

73.5 (%)

0.031

41

14

50.0 (%)

73.7 (%)

0.076

20

11

57.1 (%)

73.3 (%)

0.351

 Diabetes

26

10

22.2 (%)

29.4 (%)

0.372

22

7

26.8 (%)

36.8 (%)

0.407

4

3

11.4 (%)

20.0 (%)

0.415

 History of stroke

6

1

5.13 (%)

2.94 (%)

0.822

4

1

4.88 (%)

5.26 (%)

1.000

2

0

5.71 (%)

0 (%)

0.640

Feel depression

 Nothing

108

31

92.3 (%)

91.2 (%)

0.804

77

18

93.9 (%)

94.7 (%)

0.888

31

13

88.6 (%)

86.7 (%)

1.000

 Sometimes

8

3

6.84 (%)

8.82 (%)

4

1

4.88 (%)

5.26 (%)

4

2

11.4 (%)

13.3 (%)

 Always

1

0

0.86 (%)

0 (%)

1

0

1.22 (%)

0 (%)

0

0

0 (%)

0 (%)

 
  1. Category differences are analyzed by t-test, IADL, METs and Verbal fluency tasks are analyzed by U-test
  2. Chi-square test for ApoE, smoking and alcohol drinking habit, or Fisher’s exact test for sex, H. pylori seropositivity, C. pneumoniae seropositivity, hypertension, hyperlipidemia, diabetes, history of stroke, education
  3. CD cognitive decline, MMSE Mini-Mental State Examination, A/G albumin to globulin, H. pylori Helicobacter pylori, C. pneumoniae Chlamydia pneumoniae, ApoE apolipoprotein E, SD standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, IADL instrumental activities of daily living, METs metabolic equivalents, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, hsCRP high sensitive C-reactive protein